In Hiroshima, the city devastated by the first nuclear bomb, the biopic's Academy Awards success met a mixed reaction
India's homegrown Covaxin jab is "highly efficacious" against symptomatic Covid-19, a study by the medical journal Lancet has revealed.
The vaccine, which is developed by the Hyderabad-based Bharat Biotech, is 77.2 per cent effective against Covid-19 and 70.8 per cent effective against all variants of the SARS-CoV-2 virus.
The efficacy rate was confirmed through the evaluation of 130 confirmed cases, with 24 observed in the vaccine group, while 106 were in the placebo group.
According to the Phase 3 data published in the study, Covaxin was found to be 65.2 per cent effective against the Delta variant, 93.4 per cent effective against severe symptomatic Covid and 63.6 per cent effective against asymptomatic Covid.
Meanwhile, the World Health Organisation (WHO) on Twitter said Covaxin is “extremely suitable for low- and middle-income countries due to easy storage requirements".
As a result of that and its high efficacy rates, WHO recently added Covaxin to its approved Covid-19 vaccine list.
ALSO READ:
The Lancet study noted that further research is required to discover the vaccine's long-term safety and effectiveness, as well as its ability to protect against severe illness, hospitalisation and death.
In Hiroshima, the city devastated by the first nuclear bomb, the biopic's Academy Awards success met a mixed reaction
The Bollywood actor hosted the inaugural Hope Gala in London attended by prominent global personalities
More than 50 people are coming in to get the shot every day, doctors say
The nol cards can be used not only for public transport but also to make essential purchases at participating retail outlets in the emirate
The Italian company stands as the first Italian real estate brokerage group operating in the UAE
'The Australian batter also thinks 'there's no one better in India to have behind the stumps'
Policybazaar.ae unveils heartfelt short film advocating the need for term insurance
The app allows citizens to use digital documents on their smartphones instead of physical ones for identification and sharing purposes